Inventor · disambiguated record

Tyson D. Bowen

Also filed as: BOWEN TYSON D · Bowen Tyson

13 granted patents·15 pending applications·14 citations·filing 2016–2025

87Inventor score

Technology areasC12N C12Y C12Q C07K

Files withLIFEEDIT THERAPEUTICS INC16 LIFE EDIT THERAPEUTICS INC11 PACIFIC BIOSCIENCES CALIFORNIA INC1

Top patents by PatentIndex Score

28 records

0195US11981916B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·2 cites·38 claims
0295US11162114B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2019·Granted Nov 2, 2021·11 cites·19 claims
0391US2025084393A1Nucleic acid molecules encoding dna modifying enzymes and active fragments and variants thereof and compositions comprising the sameLIFE EDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
0490US12252718B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·0 cites·20 claims
0590US12188062B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Jan 7, 2025·0 cites·20 claims
0690US12188061B2Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the sameLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Jan 7, 2025·0 cites·22 claims
0790US2025066753A1Dna modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
0889US12252706B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·0 cites·28 claims
0988US12338455B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·0 cites·19 claims
1088US2025092398A1Polypeptides useful for gene editing and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
1187US2025066783A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
1285US12188018B2Polypeptides useful for gene editing and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·28 claims
1385US2024026384A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
1483US11981940B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted May 14, 2024·0 cites·18 claims
1583US11859181B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Granted Jan 2, 2024·0 cites·18 claims
1682US12398384B2DNA modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2022·Granted Aug 26, 2025·0 cites·16 claims
1780US2023175018A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
1880US2025283117A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
1978US2025250554A1Dna modifying enzymes and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
2077US11926843B2RNA-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2021·Granted Mar 12, 2024·0 cites·28 claims
2176US2025179529A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFE EDIT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
2275US10385387B2Methods for selectively amplifying and tagging nucleic acidsPACIFIC BIOSCIENCES CALIFORNIA INC·Filed 2016·Granted Aug 20, 2019·1 cites·16 claims
2372US2022145296A1Polypeptides useful for gene editing and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2019·Application pending·0 cites
2460US2024271162A1Rna polymerase iii promoters and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
2559US2024301385A1Dna modifying enzymes and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
2656US2023203463A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2020·Application pending·0 cites
2755US2024247242A1Uracil stabilizing proteins and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
2855US2022364074A1Rna-guided nucleases and active fragments and variants thereof and methods of useLIFEEDIT THERAPEUTICS INC·Filed 2020·Application pending·0 cites

Join the waitlist — get patent alerts

Get an alert when Tyson D. Bowen files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →